ELOXX PHARMACEUTICALS, INC. Investment Options, Exercise Price
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Investment Options, Exercise Price of $2.65 for the 0-month period ending 2014-05-16, per its 10-K filed 2014-09-29.
Discontinued › Notes
invest:InvestmentOptionsExercisePrice · last filed 2016-10-13
- 2014-05-16: Investment Options, Exercise Price 0 month $2.65.
USD
| Period end | Investment Options, Exercise Price 0 month |
|---|---|
| 2014-05-16 | $2.65 10-K · filed 2014-09-29 |
USD/shares
| Period end | Investment Options, Exercise Price 0 month |
|---|---|
| 2014-05-16 | $2.65 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |